Managed Healthcare Executive November 21, 2021
As industries across the board move towards a digital-only world, pharma companies must account for the different technologies that are transforming the R&D process.
Pharma companies have long been playing a critical role in our lives, albeit being in the background. However, COVID-19 has pushed the pharma industry firmly to the foreground. Governments and societies are pinning their hopes on the industry to help prevent the next epidemic while they continue to find cures to known health conditions and diseases.
Navigating a Complex & Fast-changing Landscape
In the wake of the pandemic, pharma companies face a growing number of challenges, especially in relation to Research and Development (R&D). Costs have spiraled over the last decade. In 2020, R&D spending in...